Sofosbuvir plus ribavirin and sofosbuvir plus ledipasvir in patients with genotype 1 or 3 hepatitis C virus and severe renal impairment: a multicentre, phase 2b, non-randomised, open-label study
Title:
Sofosbuvir plus ribavirin and sofosbuvir plus ledipasvir in patients with genotype 1 or 3 hepatitis C virus and severe renal impairment: a multicentre, phase 2b, non-randomised, open-label study
Author:
Lawitz, Eric Landis, Charles S Flamm, Steven L Bonacini, Maurizio Ortiz-Lasanta, Grisell Huang, Jonathan Zhang, Jie Kirby, Brian J De-Oertel, Shampa Hyland, Robert H Osinusi, Anu O Brainard, Diana M Robson, Richard Maliakkal, Benedict J Gordon, Stuart C Gane, Edward J